Our Medical Pharmacy Trend Report is one of a kind

Over the past 16 years, Prime Therapeutics (Prime) has seen the medical pharmacy category grow substantially. Advancements in research and technology have caused drug approvals to surge. And, while these new drugs have had a massive impact on the health and well-being of many patients with chronic or rare diseases, they can come with very high price tags. For timely updates, we’re publishing the findings in three parts this year; the full Medical Pharmacy Trend Report is scheduled for publication this fall and will include and build on earlier results with comprehensive medical benefit drug trends and forecasts.

The 2026 Medical Pharmacy Trend Report: Part 1 – Payer Survey delivers an inside look at how health plans are navigating today’s most complex and high stakes medical benefit challenges. Drawing on insights from executives representing 246 million covered lives, the report explores emerging strategies to reveal where plans are investing, where barriers persist, and what will influence decision making in the years ahead.